Product Information
DABIGATRAN ETEXILATE 150 MG CP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8569 per EA under NDC 62332063660. Its NADAC has been published 98 times since Aug 14, 2024.
Strength
150 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332063660
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA215233On Market Since
6/14/2024
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 150 MG CP has been published 98 times since Aug 14, 2024, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8569 per EA |
|---|---|
| All-time high | $2.4609 (Sep 11, 2024) |
| All-time low | $0.8446 (Feb 18, 2026) |
| 52-week high | $1.4231 |
| 52-week low | $0.8446 |
| Median price | $1.3698 |
| Average price | $1.4257 |
| Largest weekly change | +36.7% (Aug 21, 2024) |
| Weeks tracked | 98 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 150 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 150 MG CP, manufactured by Alembic Pharmaceuticals Inc., is $0.8569 per EA (NDC 62332063660), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 150 MG CP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 150 MG CP has declined 52.4%. It has been tracked across 98 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 150 MG CP?
Since Aug 14, 2024, the NADAC for DABIGATRAN ETEXILATE 150 MG CP has ranged from a low of $0.8446 (Feb 18, 2026) to a high of $2.4609 (Sep 11, 2024), with a median of $1.3698 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 150 MG CP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as DABIGATRAN ETEXILATE 150 MG CP, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 150 MG CP?
DABIGATRAN ETEXILATE 150 MG CP (NDC 62332063660) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification